Effect of Rizatriptan on Rotational Motion Sickness in Migraineurs.
Phase of Trial: Phase II
Latest Information Update: 10 Dec 2014
At a glance
- Drugs Rizatriptan (Primary)
- Indications Motion sickness
- Focus Therapeutic Use
- 07 Dec 2014 Protocol has been amended to change in treatment arms from 1 to 4.
- 07 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 30 Dec 2009 New trial record